Renaissance in antibacterial discovery from actinomycetes

Current Opinion in Pharmacology

Volumn 8, Issue 5, 2008, Pages 557-563

  Baltz, Richard H ^a  

^a CUBIST PHARMACEUTICALS INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ABYSSOMICIN C; ANDRIMID; ANIDULAFUNGIN; ANTIBIOTIC AGENT; APRAMYCIN; AVERMECTIN; BETA LACTAM ANTIBIOTIC; CAPREOMYCIN; DAPTOMYCIN; DECHLOROEREMOMYCIN; ECHINOCANDIN B; ERYTHROMYCIN; HYGROMYCIN; MACROLIDE; MONENSIN; NARASIN; NATURAL PRODUCT; ORITAVANCIN; POLYKETIDE; POLYPEPTIDE ANTIBIOTIC AGENT; SPINOSYN DERIVATIVE; STREPTOMYCIN; THIOCORALINE; TOBRAMYCIN; TYLOSIN; UNCLASSIFIED DRUG; VANCOMYCIN;

ACTINOBACTERIA; ANTIBIOTIC RESISTANCE; BACTERIAL GENE; BACTERIAL GENETICS; BACTERIAL GENOME; BACTERIAL METABOLISM; BACTERIAL STRAIN; BACTERIUM ISOLATION; DRUG INDUSTRY; DRUG SYNTHESIS; FERMENTATION; GENE CLUSTER; GLYCOSYLATION; HIGH THROUGHPUT SCREENING; MARINE ENVIRONMENT; MOLECULAR EVOLUTION; NONHUMAN; PHYSICAL CHEMISTRY; PRIORITY JOURNAL; REVIEW; SOIL; STREPTOMYCES COELICOLOR; TRANSCRIPTOMICS;

ACTINOBACTERIA; ANIMALS; ANTI-BACTERIAL AGENTS; DRUG EVALUATION, PRECLINICAL; FERMENTATION; GENOMICS; HUMANS; MULTIGENE FAMILY;

EID: 54849405130     PISSN: 14714892     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.coph.2008.04.008     Document Type: Review

References (55)

1. Payne D.J., Gwynn M.N., Holmes D.J., and Pompliano D.L. Drugs for bad bugs: confronting the challenges of antibacterial discovery. Nat Rev Drug Discov 6 (2007) 29-40. This candid review evaluates the failure of genomics-driven target-based screening of chemical libraries for antibiotic discovery at GlaxoSmithKline (previously SmithklineBeacham).
2. Baltz R.H. Antibiotic discovery from actinomycetes: will a renaissance follow the decline and fall?. SIM News 55 (2005) 186-196
3. Baltz R.H. Combinatorial biosynthesis of novel antibiotics and other secondary metabolites in actinomycetes. SIM News 56 (2006) 148-160
4. Newman D.J., and Cragg G.M. Natural products as sources of new drugs over the last 25 years. J Nat Prod 70 (2007) 461-477. This is a comprehensive review of the contribution of natural products to marketed drugs, including antibacterial agents.
5. Butler M.S., and Buss A.D. Natural products - the future scaffolds for novel antibiotics?. Biochem Pharmacol 71 (2006) 919-929
6. Baltz R.H. Natural product discovery and development at Eli Lilly and Company: one scientist's view. SIM News 55 (2005) 5-16
7. Baltz R.H. Antimicrobials from actinomycetes: back to the future. Microbe 2 (2007) 125-131
8. Watve G., Tickoo R., Jog M.M., and Bhole B.D. How many antibiotics are produced by the genus Streptomyces?. Arch Microbiol 176 (2001) 391-392
9. Fiedler H.-P., Bruntner C., Bull A.T., Ward A.C., Goodfellow M., Potterat O., Puder C., and Mihm G. Marine actinomycetes as a source of novel secondary metabolites. Antonie van Leeuwenhoek 87 (2005) 37-42
10. Ward A.C., and Bora N. Diversity and biogeography of marine actinobacteria. Curr Opin Microbiol 9 (2006) 1-8
11. Bull A.T., and Stach J.E.M. Marine actinobacteria: new opportunities for natural product search and discovery. Trends Microbiol 15 (2007) 491-499
12. Gontang E.A., Fenical W., and Jensen P.R. Phylogenetic diversity of Gram-positive bacteria cultured from marine sediments. Appl Environ Microbiol 73 (2007) 3272-3282
13. Fenical W., and Jensen P.R. Developing a new resource for drug discovery: marine actinomycete bacteria. Nat Chem Biol 2 (2006) 666-673
14. Bredholdt H., Galatenko O.A., Engelhardt K., Fjærvik E., Terekhova L.P., and Zotchev S.B. Rare actinomycete bacteria from the shallow water sediments of the Trodheim fjord, Norway: isolation, diversity and biological activity. Environ Microbiol 9 (2007) 2756-2764
15. Panthom-aree W., Stach J.E.M., Ward A.C., Horikoshi K., Bull A.T., and Goodfellow M. Diversity of actinomycetes isolated from challenger deep sediment (10,898 m) from the Mariana Trench. Extremophiles 10 (2006) 181-189. Isolation of actinomycetes from a depth of over 10 000 m confirms that actinomycetes are indeed ubiquitous in marine sediments.
16. Bentley S.D., Chater K.F., Cerdeno-Tarraga A.M., Challis G.L., Thomson N.R., James K.D., Harris D.E., Quail M.A., Kieser H., Harper D., et al. Complete genome sequence of the model actinomycete Streptomyces coelicolor A3(2). Nature 417 (2002) 141-147
17. Ikeda H., Ishikawa J., Hanamoto A., Shinose M., Kikuchi H., Shiba T., Sakaki Y., Hattori M., and Ōmura S. Complete genome sequence and comparative analysis of the industrial microorganism Streptomyces avermitilis. Nat Biotechnol 21 (2003) 526-531
18. liynyk M., Samborskyy M., Lester J.B., Mironenko T., Scott N., Dickens S., Haydock S.F., and Leadlay P.F. Complete genome sequence of the erythromycin-producing bacterium Saccharopolyspora erythraea NRRL23338. Nat Biotechnol 25 (2007) 447-453. Unlike Streptomyces species, this terrestrial actinomycete has a circular genome, but like streptomycetes it has many potential secondary metabolite biosynthetic pathways.
19. Udwary D.W., Zeigler L., Asolkar R.N., Singan V., Lapidus A., Fenical W., Jensen P.R., and Moore B.S. Genome sequencing reveals complex secondary metabolome in the marine actinomycete Salinispora tropica. Proc Natl Acad Sci U S A 104 (2007) 10376-10381. This work establishes that obligate marine actinomycetes can encode multiple secondary metabolic biosynthetic pathways to produce novel compounds not observed from terrestrial actinomycetes.
20. McLeod M.P., Warren R., Hsiao W.W.L., Araki N., Myhre M., Fernandes C., Miyazawa D., Wong W., Lillquist A.L., and Wang D. The complete genome of Rhodococcus sp. RHA1 provides insights into a catabolic powerhouse. Proc Natl Acad Sci U S A 103 (2006) 15582-15587. This work extends the notion that diverse actinomycete genera have the coding capacity for multiple cryptic secondary metabolite biosynthetic pathways.
21. Zazopoulos E., Huang K., Staffa A., Liu W., Bachmann B.O., Nonaka K., Ahlert J., Thorson J.S., Shen B., and Farnet C.M. A genomics-guided approach for discovering and expressing cryptic metabolic pathways. Nat Biotechnol 21 (2003) 187-190
22. McAlpine J.B., Bachmann B.O., Piraee M., Tremblay S., Alarco A.M., Zazopoulos E., and Farnet C.M. Microbial genomics as a guide to drug discovery and structure elucidation: ECO-02301, a novel antifungal agent, as an example. J Nat Prod 68 (2005) 493-496
23. Banskota A.H., McAlpine J.B., Sorensen D., Ibrahim A., Aouidate M., Piraee M., Alarco A.-M., Farnet C.M., and Zazopoulos E. Genomic analyses lead to novel secondary metabolites. Part 3. ECO-0501, a novel antibacterial of a new class. J Antibiot 59 (2006) 533-542
24. Gross H., Stockwell V.O., Henkels M.D., Nowak-Thompson B., Loper J.E., and Gerwick W.H. The genomisotopic approach: a systematic method to isolate products of orphan biosynthetic gene clusters. Chem Biol 14 (2007) 53-63
25. Challis G.L., and Hopwood D.A. Synergy and contingency as driving forces for the evolution of multiple secondary metabolite production by Streptomyces species. Proc Natl Acad Sci U S A 100 (2003) 14555-14561
26. Karoonuthaisiri N., Weaver D., Huang J., Cohen S.N., and Kao C.M. Regional organization of gene expression in Streptomyces coelicolor. Gene 353 (2005) 53-66
27. Peano C., Bicciato S., Corti G., Ferrari F., Rizzi E., Bonnal R., Bordoni R., Albertini A., Bernardi L., Donadio S., and De Bellis G. Complete gene expression profiling of Saccharopolyspora erythraea using GeneChip DNA microarrays. Microb Cell Fact 6 (2007) 37
28. Baltz R.H. Molecular engineering approaches to peptide, polyketide and other antibiotics. Nat Biotechnol 24 (2006) 1533-1540
29. Berner M., Krug D., Bihlmaier C., Vente A., Müller R., and Bechthold A. Genes and enzymes involved in caffeic acid biosynthesis in the actinomycete Saccharothrix espanaensis. J Bacteriol 188 (2006) 2666-2673
30. Penn J., Whiting A., Wrigley S.W., Latif M., Gibson T., Silva C.J., Li X., Miao V., Brian P., and Baltz R.H. Heterologous production of daptomycin in Streptomyces lividans. J Indust Microbiol Biotechnol 33 (2006) 121-128
31. Lombó F., Velasco A., Castro A., de la Calle F., Braña A.F., Sánchez-Puelles J.M., Méndez C., and Salas J.A. Deciphering the biosynthetic pathway of the antitumor thiocoraline from a marine actinomycete and its expression in two Streptomyces species. ChemBioChem 7 (2006) 366-376. This work demonstrates that the thiocoraline biosynthetic genes from a slow growing marine Micromonospora endosymbiont from a mollosk can be expressed in faster growing Streptomyces species to produce thiocoraline.
32. Neumann C.S., Fujimori D.G., and Walsh C.T. Halogenation strategies in natural product biosynthesis. Chem Biol 15 (2008) 99-109
33. Hornung A., Bertazzo M., Dziarnowski A., Schneider K., Welzel K., Wohlert S.-E., Holzenkämpfer, Nicholson G.J., Bechthold A., Süssmuth R.D., et al. A genomic screening approach to the structure-guided identification of drug candidates from natural sources. ChemBioChem 8 (2007) 757-766. Conserved sequences from diverse halogenase genes were used to identify actinomycetes encoding related, but distinct novel genes and linked novel secondary gene clusters accessible to cloning and expression in heterologous streptomycete hosts.
34. Luzhetskyy A., Weiss H., Charge A., Welle E., Linnebrink A., Vente A., and Bechthold A. A strategy for cloning glycosyltransferase genes involved in natural product biosynthesis. Appl Microbiol Biotechnol 75 (2007) 1367-1375
35. Donadio S., Monciardini P., and Socio M. Polyketide synthases and nonribosomal peptide synthetases: the emerging view from bacterial genomics. Nat Prod Rep 24 (2007) 1073-1109. This critical analysis of PKS and NRPS genes in sequenced bacterial genomes dispels the notion that the 99% of uncultured microbes with small genomes will add significantly to the discovery of novel antibiotics and other secondary metabolites.
36. Jenke-Kodama H., Börner T., and Dittman E. Natural biocombinatorics in the polyketide synthase genes of the actinobacterium Streptomyces avermitilis. PLoS Comput Biol 2 (2006) e132
37. Ridley C.P., Lee H.Y., and Khosla C. Evolution of polyketide synthases in bacteria. Proc Natl Acad Sci U S A 105 (2008) 4595-4600
38. Baltz R.H. Biosynthesis and genetic engineering of lipopeptide antibiotics related to daptomycin. Curr Top Med Chem 8 (2008) 618-638
39. Fischbach M.A., Walsh C.T., and Clardy J. The evolution of gene collectives: how natural selection drives chemical innovation. Proc Natl Acad Sci U S A 105 (2008) 4601-4608
40. Fischbach M.A., and Walsh C.T. Assembly-line enzymology for polyketide and nonribosomal peptide antibiotics: logic, machinery, and mechanisms. Chem Rev 106 (2006) 3468-3496
41. Weissman K.J., and Leadlay P.F. Combinatorial biosynthesis of reduced polyketides. Nat Rev Microbiol 3 (2005) 925-936
42. Khosla C., Tang Y., Chen A.Y., Schnarr N.A., and Cane D.E. Structure and mechanism of the 6-deoxyerythronolide B synthase. Annu Rev Biochem 76 (2007) 195-221
43. Sieber S.A., and Marahiel M.A. Molecular mechanisms underlying nonribosomal peptide synthesis: approaches to new antibiotics. Chem Rev 105 (2005) 715-738
44. Luzhetskyy A., Vente A., and Bechthold A. Glycosyltransferases involved in the biosynthesis of biologically active natural products that contain oligosaccharides. Mol Biosyst 1 (2005) 117-126
45. Kopp F., and Marahiel M.A. Where chemistry meets biology: the chemoenzymatic synthesis of nonribosomal peptides and polyketides. Curr Opin Biotechnol 18 (2007) 513-520
46. Blanchard S., and Thorson J.S. Enzymatic tools for engineering natural product glycosylation. Curr Opin Chem Biol 10 (2006) 263-271
47. Zhang C., Griffith B.R., Fu Q., Albermann C., Fu X., Lee I.-K., Li L., and Thorson J.S. Exploiting the reversibility of natural product glycosyltransferase-catalyzed reactions. Science 313 (2006) 1291-2194
48. Waldron C., Matsushima P., Rosteck P.R., Broughton M.C., Turner J., Madduri K., Crawford K.P., Merlo D.J., and Baltz R.H. Cloning and analysis of the spinosad biosynthetic gene cluster of Saccharopolyspora spinosa. Chem Biol 8 (2001) 487-499
49. Hahn D.R., Gustafson G., Waldron C., Bullard B., Jackson J.D., and Mitchell J. Butenyl-spinosyns, a natural example of genetic engineering of antibiotic biosynthetic genes. J Ind Microbiol Biotechnol 33 (2006) 94-104
50. Sheehan L.S., Lill R.E., Wilkenson B., Sheridan R.M., Vousden W.A., Kaja A.L., Crouse G.D., Gifford J., Graupner P.R., Karr L., et al. Engineering the spinosyn PKS: directing starter unit incorporation. J Nat Prod 69 (2006) 1702-1710. This work demonstrates that genetic engineering coupled with precursor feeding can expand the spectrum of an commercially important insecticidal polyketide to include aphids.
51. Miao V., Coëffet-LeGal M.-F., Nguyen K., Brian P., Penn J., Whiting A., Steele J., Kau D., Martin S., Ford R., et al. Genetic engineering in Streptomyces roseosporus to produce hybrid lipopeptide antibiotics. Chem Biol 13 (2006) 269-276
52. Nguyen K., Ritz D., Gu J.-Q., Alexander D., Chu M., Miao V., Brian P., and Baltz R.H. Combinatorial biosynthesis of lipopeptide antibiotics related to daptomycin. Proc Natl Acad Sci U S A 103 (2006) 17462-17467. This work showed that very active derivatives of a commercially important antibiotic, daptomycin, can be generated by combinatorial biosynthesis.
53. Fischbach M.A., Lai J.R., Roche E.D., Walsh C.T., and Liu D.R. Directed evolution can rapidly improve the activity of chimeric assembly-line enzymes. Proc Natl Acad Sci U S A 104 (2007) 11951-11956. They used up to three rounds of error-prone PCR to greatly improve the activity of engineered hybrid NRPS/PKS enzymes.
54. Williams G.J., Zhang C., and Thorson J.S. Expanding the promiscuity of a natural-product glycosyltransferase by directed evolution. Nat Chem Biol 3 (2007) 657-662. The specificities for acceptor substrates and donor NDP-sugars were vastly broadened by making three amino acid substitutions in a glycosyltransferase with naturally stringent substrate specificity.
55. Cuatrecasas P. Drug discovery in jeopardy. J Clin Invest 116 (2006) 2837-2842. This candid assessment of the current status in the pharmaceutical industry calls for a larger role for nonprofit institutions to reinvigorate a more creative and innovating drug discovery process.